Found: 23
Select item for more details and to access through your institution.
Impact of aPTT reagents on measurement of a PEGylated recombinant FVIII (Adynovi<sup>®</sup>/Adynovate<sup>®</sup>): A French multicentric field assay study.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prospective evaluation of two specific IgG immunoassays (HemosIL<sup>®</sup> AcuStar HIT‐IgG and HAT45G<sup>®</sup>) for the diagnosis of heparin‐induced thrombocytopenia: A Bayesian approach.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 3, p. 468, doi. 10.1111/ijlh.13404
- By:
- Publication type:
- Article
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 6, p. 675, doi. 10.1111/ejh.13490
- By:
- Publication type:
- Article
Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 103, doi. 10.1111/ejh.13423
- By:
- Publication type:
- Article
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1226, doi. 10.3390/jcm9041226
- By:
- Publication type:
- Article
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
- Published in:
- Pharmaceutics, 2020, v. 12, n. 4, p. 380, doi. 10.3390/pharmaceutics12040380
- By:
- Publication type:
- Article
Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 282, doi. 10.1111/hae.13946
- By:
- Publication type:
- Article
Dosage de l'activité du facteur IX chez les patients hémophiles B substitués.
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 18, doi. 10.1684/hma.2019.1491
- By:
- Publication type:
- Article
Dosage de l'activité du facteur VIII chez les patients hémophiles A substitués.
- Published in:
- Hematologie, 2019, v. 25, n. 6, p. 298, doi. 10.1684/hma.2019.1492
- By:
- Publication type:
- Article
Multicentre evaluation of CK Prest<sup>®</sup> for assaying plasma levels of factor IX fused with albumin (Idelvion<sup>®</sup>).
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. e327, doi. 10.1111/hae.13812
- By:
- Publication type:
- Article
Estimation of Nuwiq<sup>®</sup> (simoctocog alfa) activity using one‐stage and chromogenic assays—Results from an international comparative field study.
- Published in:
- Haemophilia, 2019, v. 25, n. 4, p. 708, doi. 10.1111/hae.13763
- By:
- Publication type:
- Article
Dosage de l'activité du facteur IX chez les patients hémophiles B substitués.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 1, p. 41, doi. 10.1684/abc.2019.1414
- By:
- Publication type:
- Article
Dosage de l'activité du facteur VIII chez les patients hémophiles A substitués.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 1, p. 53, doi. 10.1684/abc.2019.1413
- By:
- Publication type:
- Article
Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 811, doi. 10.1111/bjh.14955
- By:
- Publication type:
- Article
A rapid test ( STic Expert<sup>®</sup>) for the diagnosis of heparin-induced thrombocytopenia - response to De Cooman and Devreese.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 466, doi. 10.1111/bjh.13490
- By:
- Publication type:
- Article
Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay ( STic Expert<sup>®</sup> HIT) for the diagnosis of heparin-induced thrombocytopenia.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 5, p. 774, doi. 10.1111/bjh.12939
- By:
- Publication type:
- Article
Characteristics, Mechanisms of Action, and Epitope Mapping of Anti-factor VIII Antibodies.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2009, v. 37, n. 2, p. 67, doi. 10.1007/s12016-009-8119-0
- By:
- Publication type:
- Article
Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 6, p. 550, doi. 10.1111/j.1600-0609.2007.00959.x
- By:
- Publication type:
- Article
Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
- Published in:
- British Journal of Haematology, 2005, v. 128, n. 6, p. 837, doi. 10.1111/j.1365-2141.2005.05381.x
- By:
- Publication type:
- Article
Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 5, p. 786, doi. 10.1046/j.1365-2141.2003.04363.x
- By:
- Publication type:
- Article
Anti-β<sub>2</sub>-glycoprotein I antibodies recognizing platelet factor 4heparin complex in antiphospholipid syndrome in patient substantiated with mouse Model.
- Published in:
- Journal of Molecular Recognition, 2003, v. 16, n. 3, p. 125, doi. 10.1002/jmr.619
- By:
- Publication type:
- Article
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
- Published in:
- British Journal of Haematology, 1997, v. 99, n. 2, p. 273, doi. 10.1046/j.1365-2141.1997.4183225.x
- By:
- Publication type:
- Article